Source: Annual Congress 2005 - Cardiovascular consequences of OSA
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. R. Proctor, R. Lamb, C. G. Billings, E. D. Moloney (Sheffield, United Kingdom). Unrecognised hypertension in patients screened for obstructive sleep apnoea. Eur Respir J 2005; 26: Suppl. 49, 371

Member's Comments

No comment yet.

Related content which might interest you: Unrecognised systemic hypertension in patients with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 643s Year: 2006 Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Prevalence of obstructive sleep apnea among patients with resistant arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 115s Year: 2005 Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 Should patients with obstructive sleep apnea syndrome be screened for hypothyroidism? Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005 Prevalence of stroke in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007 Recommendations for the management of patients with obstructive sleep apnoea and hypertension Source: Guidelines 2013 Year: 2013 Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients. Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019 Prevalence of obstructive airway disease in patients with obstructive sleep apnea Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012 The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002 Prevalence of thyroid disease in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011 Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease Source: Eur Respir J 2013; 41: 616-620 Year: 2013 Investigating for dyslipidemia in those being referred for suspected obstructive sleep apnoea Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011 Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new? Year: 2020 Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Masked hypertension and obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 416s Year: 2006 Hypertension and obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Comorbidities of obstructive sleep apnoea syndrome Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011